跳转到主要内容

Rigaku Reorganization Unifies Company To Better Serve Customers Outside of Japan

Rigaku Reorganization Unifies Company To Better Serve Customers Outside of Japan

The Woodlands, TX — October 14, 2005. Rigaku today announced a reorganization whereby the various operating companies and divisions of Rigaku, serving markets external to Japan and its core sales territories, began to operate as a single company. As of September 1, 2005, Rigaku Americas Corporation (RAC) became the operating entity in charge of North America.

Over the last decade, Rigaku has acquired or founded a number of companies in order to develop a technology portfolio capable of sustained innovation for core markets. During this period of high growth, the new additions retained their individual company identities. With key capabilities now in place, top level integration will maximize the quality of solutions available to our customers while expediting the rollout of new advances.

Henceforth, all marketing and advertising material will brand the company solely as "Rigaku". The new, combined organization (RAC) includes: Rigaku/MSC, Osmic, RoboDesign, Molecular Images, Electronic Imaging Technologies, Molecular Metrology, and the Vacuum Products division. ActiveSight, our contract research organization (CRO), servicing the pharmaceutical and biotech markets, will continue to operate as a separate entity. The former Rigaku/MSC operation in the U.K will now be known as Rigaku Europe.

From a legal and formal standpoint, the transition will take place over the next few months, with the completion targeted for March 1, 2006. Rigaku's goal has always been, and continues to be, to provide industry leading innovation with a customer-friendly approach. This top-level restructuring, along with the associated consistent corporate identity, will enable the company to satisfy our corporate mission in a more effective manner.

Rigaku—Leading With Innovation

Since its inception in Japan in 1951, Rigaku Corporation has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on life sciences and general purpose analytical instrumentation. With hundreds of major innovations to its credit, Rigaku and its subsidiary companies are world leaders in the fields of small molecule and protein crystallography, X-ray spectrometry & diffraction, X-ray optics, as well as semiconductor metrology. Rigaku employs over 1,100 people in the manufacture and support of its analytical equipment. Its products are in use in more than 70 countries - supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial community.

For further information, contact:

Paul N. Swepston, Ph.D.
President & CEO